POSTTRANSLATIONAL PROCESSING OF THE NEUROTENSIN NEUROMEDIN-N PRECURSOR IN THE CENTRAL-NERVOUS-SYSTEM OF THE RAT .1. BIOCHEMICAL-CHARACTERIZATION OF MATURATION PRODUCTS
F. Denadai et al., POSTTRANSLATIONAL PROCESSING OF THE NEUROTENSIN NEUROMEDIN-N PRECURSOR IN THE CENTRAL-NERVOUS-SYSTEM OF THE RAT .1. BIOCHEMICAL-CHARACTERIZATION OF MATURATION PRODUCTS, Neuroscience, 60(1), 1994, pp. 159-166
Neurotensin and neuromedin N are two biologically active related pepti
des which are encoded in the same precursor molecule. In the rat, the
precursor consists of a 169-residue polypeptide containing in its C-te
rminal region one copy each of neurotensin and neuromedin N. Four Lys-
Arg sequences which are thought to represent putative processing sites
occur in the precursor molecule. Of these sites, the three that are c
losest to the C-terminus flank and separate neurotensin and neuromedin
N. The fourth precedes a neuromedin N-like sequence. The present stud
ies were aimed at determining the extent to which each of these four d
ibasic sites is cleaved and at identifying and quantifying the interme
diate and mature products to which this cleavage gives rise in extract
s from whole rat brain, hippocampus and globus pallidus. This was achi
eved by means of radioimmunoassays specific for sequences of the neuro
tensin/neuromedin N precursor that are adjacent to the dibasic process
ing sites used in combination with high pressure liquid chromatography
and arginine-directed trypsin digestion of tissue extracts. In all ti
ssue extracts, it was found that the three most C-terminal dibasic pro
cessing sites in the neurotensin/neuromedin N precursor are processed
to a similar extent, whereas the dibasic site that precedes the neurom
edin N-like sequence is processed to a lesser extent. As reported prev
iously, the globus pallidus was shown to contain proportionally lower
levels of neuromedin N than other brain regions. This lower content wa
s not the consequence of a lack of precursor processing at the dibasic
site that flanks the N-terminus of neuromedin N but, rather, resulted
from atypical cleavage of this site or from differential post-process
ing disposal of neuromedin N. The high levels of precursor messenger R
NA previously reported by others in the hippocampus relative to other
brain regions were not matched by high concentrations of precursor-der
ived products. In conclusion, the immunological and biochemical approa
ches described here provide powerful means for establishing the proces
sing pattern of the neurotensin/neuromedin N precursor in brain region
s. The present data set the biochemical basis for the immunohistochemi
cal studies on the regional and cellular brain distribution of neurote
nsin/neuromedin N precursor-derived peptides, as reported in a compani
on paper.